共 32 条
Plasmodium falciparum CTP:phosphocholine cytidylyltransferase possesses two functional catalytic domains and is inhibited by a CDP-choline analog selected from a virtual screening
被引:11
作者:
Contet, Alicia
[1
]
Pihan, Emilie
[2
]
Lavigne, Marina
[1
]
Wengelnik, Kai
[1
]
Maheshwari, Sweta
[1
]
Vial, Henri
[1
]
Douguet, Dominique
[2
]
Cerdan, Rachel
[1
]
机构:
[1] Univ Montpellier, CNRS, Dynam Interact Membranaires Normales & Pathol, UMR 5235, F-34095 Montpellier, France
[2] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cell, UMR 7275, F-06560 Valbonne, France
关键词:
Malaria;
Phosphatidylcholine;
CTP:phosphocholine cytidylyltransferase (EC 2.7.7.15);
Kinetic parameter;
Drug target;
Structure-based virtual screening;
Inhibitor;
CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE;
PHOSPHOETHANOLAMINE METHYLTRANSFERASE;
AMPHIPATHIC HELIX;
STRUCTURAL BASIS;
MALARIA;
BIOSYNTHESIS;
ALIGNMENT;
PATHWAY;
ENZYME;
SALTS;
D O I:
10.1016/j.febslet.2015.03.003
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Phosphatidylcholine is the major lipid component of the malaria parasite membranes and is required for parasite multiplication in human erythrocytes. Plasmodium falciparum CTP:phosphocholine cytidylyltransferase (PfCCT) is the rate-limiting enzyme of the phosphatidylcholine biosynthesis pathway and thus considered as a potential antimalarial target. In contrast to its mammalian orthologs, PfCCT contains a duplicated catalytic domain. Here, we show that both domains are catalytically active with similar kinetic parameters. A virtual screening strategy allowed the identification of a drug-size molecule competitively inhibiting the enzyme. This compound also prevented phosphatidylcholine biosynthesis in parasites and exerted an antimalarial effect. This study constitutes the first step towards a rationalized design of future new antimalarial agents targeting PfCCT. (C) 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:992 / 1000
页数:9
相关论文